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Abstract
The ability to accurately classify disease subtypes is of vital importance, especially
in oncology where this capability could have a life saving impact. Here we report
a classification between two subtypes of non-small cell lung cancer, namely Adeno-
carcinoma vs Squamous cell carcinoma. The data consists of approximately 20,000
gene expression values for each of 104 patients. The data was curated from [1] [2].
We used an amalgamation of classical and and quantum machine learning models
to successfully classify these patients. We utilized feature selection methods based
on univariate statistics in addition to XGBoost [3]. A novel and proprietary data
representation method developed by one of the authors called QCrush was also used
as it was designed to incorporate a maximal amount of information under the size
constraints of the D-Wave quantum annealing computer. The machine learning was
performed by a Quantum Boltzmann Machine. This paper will report our results, the
various classical methods, and the quantum machine learning approach we utilized.
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1 Introduction
The primary purpose of this paper is to elaborate on the process we used to classify
two specific lung cancers, namely Adenocarcinoma and Squamous Cell Carcinoma,
from a 20,000 gene expression set using a combination of classical and quantum ma-
chine learning models. In the process of achieving consistent classification we utilized
a process of iterative hyper-tuning. This paper will focus largely on the algorithms
and procedures used to complete computations with the Quantum Processing Unit
(QPU) provided by D-Wave to harness its unique ability to enhance specific opera-
tions used for our classification of lung cancers.
In the spirit of the work in [4] we would like to disclose that there were no attempts
at demonstrating some type of quantum supremacy here. It is believed that classical
machine learning will dominate the landscape of data science for many years while
serious quantum computational hardware challenges are met. However, it is believed
that near term devices will be able to provide impressive advantages for certain tasks
and that hybrid classical and quantum methods will be a way forward. With that
in mind, we utilize the ability of quantum annealers to generate complex probability
distributions to aid a machine learning protocol in the arena of medicine.
2 Precision Medicine and Machine Learning
The idea that complex disorders like Alzheimer’s disease, and many cancers, are in
fact syndromes consisting of several sub-diseases is not new. However, our ability to
better stratify patient populations for these disorders arrived with machine learning.
Oncology led the way with what we refer to as biomarkers [5], which are sets of
variables that one can measure from a patient, like gene expression or cholesterol
level, that can be used to make a prediction or determination about a person’s
health. For example, will a patient respond to some specific treatment, or is a
patient at risk for having at heart attack in the near future? Terms like personalized
and precision medicine are usually used interchangeably, but a preference in general
has emerged for precision medicine. This is simply because the term personalized
seems to imply a treatment designed for one person specifically, which may occur in
the future, whereas the term precision is based on the idea that we could understand
a true subtype that a patient lies within and for whom a particular treatment may
be optimal. Machine learning is making this a reality and models already exist that
influence cancer and other treatments [6].
In addition to the very important work which focuses on making treatments for
patients more precise, precision medicine through machine learning is also influenc-
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ing drug design. The reason for wanting to do this is simple: if one says that they
are going to design a drug for Alzheimer’s, what do they really mean? What mech-
anism of action is this drug going to have? Machine learning is beginning to reveal
that Alzheimer’s and other disorders have multiple distinct manifestations that may
likely require different interventions. Thus, work is commencing to precisely define
these subtypes and what molecular machinery drives them, and this knowledge is
going to influence the next generation of drug design. As quantum computers ma-
ture, quantum machine learning will play a role at both ends of this process. On the
one hand, quantum computers provide a natural computational environment for the
exploration of molecules, being that molecules are quantum mechanical structures.
On the other hand, their ability to utilize quantum parallelism may be utilized to
understand patient subpopulations. In the meanwhile, the machine learning proto-
cols available for systems like the D-Wave 2000Q is allowing researchers to create
patient response protocols that may one day influence clinical decisions. We present
a unique effort in this paper by utilizing the D-Wave 2000Q computer to create a
cancer biomarker, but there has already been some effort in the medical space in-
cluding the work in [7] which attempts to explore the potential impact that quantum
machine learning may have on a computational biology problem. In addition to this,
there have been various efforts in utilizing quantum annealers to model drugs and
their interactions with proteins. One may refer to [8] to learn about the many, albeit
potentially premature yet exciting, commercial efforts commencing in this space.
3 Quantum Computation and Quantum Processing Unit
At the heart of a quantum computer is the Quantum Processing Unit (QPU) which
provides a way to encode information in what is referred to as quantum bits (qubits)
[9]. A quantum bit, likened to a classical bit contains information that the machine
uses to conduct operations. Unlike a classical bit the quantum bit does not default to
a 0 or 1, rather it occupies a state that is in, what is referred to as, a superposition[10]
of 0 and 1 with an underlying probability[11]. Once the qubit is measured by an
observation, the qubit finds itself in a definite state of either 0 or 1, like an ordinary
classical computer. The fact that the qubit, or more accurately, that the set of qubits
within the computer, is in a superposition allows the machine to use quantum me-
chanics to evolve its state. This property, in addition to entanglement[10], produces
a situation where the amount of information that can be simultaneously represented
in one state of the quantum computer is exponentially greater than what can rep-
resented in a classical machine. In other words, if you have two qubits, a quantum
computer can be in all 4 states |00〉, |01〉, |10〉, and |11〉 simultaneously while a clas-
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sical computer can only be in one of these four states in any moment. This does
mean that a quantum computing programmer has access to quantum mechanical
properties and can evolve a state in a way that classical computers cannot, and thus
perform some novel computations through quantum algorithms. This does not mean
that quantum computers are in general exponentially faster, though they can per-
form some computations more efficiently. To be mathematically rigorous, if BQP
are the class of problems that quantum computers can make a decision about in
polynomial time, the the actual relationship between BQP and NP is not known[10].
Ultimately, the advent of quantum computers like the D-Wave computer repre-
sents the culmination of years of effort and the achievement is remarkable. Never-
theless, these modern quantum computers are still not superior in any practical way,
however our ability to model lung cancer with such a machine indicates that as these
machines scale, we will be able to access them to understand patient populations in a
way not possible with classical computers. We will now review the D-Wave machine
briefly.
.
Figure 1: D-Wave Quantum Processing Unit Arranged by Unit Cells
The architecture of the Quantum Processing Unit used by D-Wave is a chimera
graph as shown in figure 1.The paradigm of quantum computation that the D-Wave
computer uses is known as annealing Quantum Computation or Quantum Annealing
(QA) [12]. Essentially, one first needs to understand that a problem can be encoded
in an energy functional called a Hamiltonian. Next, note that in the D-Wave system
one can start with a simple Hamiltonian in its ground state and then allow the
technology to change its internal configuration in such a way so that it will end up in
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the ground state of the Hamiltonian that encodes the problem of interest. This has
to be done in a very precise and time sensitive way, but is clearly possible[13]. This
allows us to solve a certain Hamiltonian required to learn about our cancer patients
through Quantum Boltzmann Machines. See [7] for more information on the QA
paradigm.
4 Boltzmann Machine
A Boltzmann Machine is a generative machine learning model that is trained to en-
code the underlying distribution of a given dataset [14]. A Restricted Boltzmann
Machine (RBM), a subset of Boltzmann Machines, is a bipartite graph that is seg-
mented into visible and hidden neurons. The neurons of the visible layer are strongly
connected to those in the hidden layer, but there exist no adjacent edges between
neurons belonging to the same layer. We chose to use a RBM in our experiment
because its training is less computationally expensive than a standard Boltzmann
Machine [15]. See figure 2.
.
Figure 2: A Simple Restricted Boltzmann Machine Consisting of 4 Visible and 3
Hidden Nodes. Note the absence of intralayer edges.
Once trained, RBMs produce reconstructions of the provided data [15]. One
method of training, optimizing the weights of, an RBM is Contrastive Divergence,
which is achieved by Gibbs sampling and gradient descent[16]. It is important to
understand the workings of a Restricted Boltzmann Machine as it provides the foun-
dation for understanding the training of Boltzmann machines on the D-Wave quan-
tum annealer via the quantum sampler. Keep in mind that the idea to utilize this
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paradigm of machine learning was natural as the fundamental architecture of the
Quantum Processing Unit closely resembles the graphical structure of an RBM.[17]
4.1 Restricted Boltzmann Machine
An RBM contains three parameters that encode the entire model:
i) the bias vector for the visible layer (length n)
ii) the bias vector for the hidden layer (length m)
iii) the weights matrix that represents the edge weight for each connection between
the visible and hidden layer (m by n)
Once these three parameters are trained the RBM should be able to create reliable
reconstructions of the data that it is provided. The significant hyper-parameters of
a RBM are the learning rate and the number of hidden neurons. The learning rate
simply determines the magnitude of change made to the parameters, and the number
of hidden neurons determines the degree of information compression that occurs. By
tuning the hyper-parameters you should be able to create a model that reconstructs
the data provided with a high degree of accuracy.
The Boltzmann equation determines the energy of a system. In the context of an
RBM this means the equation is as follows:
E(v, h) = −
∑
i
aivi −
∑
j
bjhj −
∑
i
∑
j
viwi,jhj (1)
The parameters that we seek to tune with training are the weights matrix, and
the two bias vectors a and b. In matrix form:
E(v, h) = −aTv − bTh− vTWh (2)
To put this in perspective consider that energy based methods are designed to
minimize an energy functional, as given by E(v, h) above, for example. The proposed
system is essentially trying to capture relationships between variables. Thus, if we
train this system to minimize E(v, h) then lower energy configurations will be favored
by the system. This is because a standard way of computing the joint probability
between v and h is given by
P (v, h) =
exp(−E(v, h))∑
v,h exp(−E(v, h))
(3)
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Thus, because we minimize E(v, h), we end up maximizing
P (v) =
∑
h exp(−E(v, h))∑
v,h exp(−E(v, h))
(4)
Once this maximization occurs, we will have a system that will reflect the dis-
tribution of the training set. We will not go into the technicalities of how this is
accomplished here, however there are standard references available [18]. The essen-
tial idea for the reader to understand is that this system generalizes well on the
D-Wave machine due to the architecture of the system. More specifically, the con-
nectivity of the QPU given in figure 1, can be utilized to define a system that is the
quantum analogy of the Restricted Boltzmann Machines just described [19].
4.2 Restricted Boltzmann Machine for Classification
Being able to reconstruct gene expression data is useful, yet it isn’t immediately
apparent how it can be used to classify different subtypes of lung cancer. As RBMs
are not ordinary neural networks with well defined cost functions and conventional
back-propagation they cannot be trained simply by employing usual methods. One
method of classification is to use a neural network classifier that uses the hidden
variables as the input. Please see figure 3.
Another method, and the one used for our experiment is to clamp visible neurons
with the class in which they belong and train the RBM to be able to reconstruct
those clamped values[20]. For example, if a dataset contains 100 patients that are
either male or female, and 50 variables: one would construct an RBM with 50 visible
neurons + 2 visible neurons that will contain the class information (clamp), for a
total of 52 visible neurons. When training, the 50 variables would be fed into the
RBM as usual, with [1, 0] as the clamp value for male and [0, 1] for female. Thus
the RBM, which is agnostic to the order of the data being fed in, would learn the
distribution of data in relation to the clamp. In essence it would learn that when
the 50 variables are distributed in a certain way the clamp is distributed in a unique
way as well (particularly either [1, 0] or [0, 1]).
Once the model is trained with a clamp (see figure 4), its accuracy can be validated
by feeding a new patient vector with a neutral clamp [1, 1] and evaluating the result
by collapsing the larger of the clamp values to a 1 and the other to a 0. E.g. if
a 50 variable patient vector is fed into the RBM with a neutral clamp [1,1], the
reconstruction would be a fuzzy reconstruction of the patient vector with the clamp
value [0.23, 0.48] which we would collapse to [0, 1], i.e., prediction would be female.
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Figure 3: Model of a Possible Architecture Used to Classify Samples Consisting of
an RBM and Classifier
It is important to note that you need an equal number of clamped neurons as the
number of classes present in the dataset in order to provide a one-hot encoded clamp.
5 Mapping A Boltzmann Machine To The QPU
With a better understanding of an RBM we can begin to understand the basis of
how we utilize the D-Wave machine to train the RBM. At the simplest level, the
chimera structure allows one to map the classical RBM to the QPU. A difference
now is that the Hamiltonian of this new system consists of an energy where the spin
terms in E(h, v) above are replaced by operators[21], however the same three param-
eters exist for this mapped system as the classical RBM we defined. In essence, to
train a generative model you must have some insight into the underlying probability
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Figure 4: Method of Classifying Samples Using a Clamp
distribution of the data. Since determining the true distribution is a computationally
expensive task we sample from the distribution instead. For example, if you want
to know the underlying distribution of the sum of two dice throws you can sample
from the distribution to gain further insight. Samples would be like: 2, 6, 7, 9, 7,
11, 3, 6, etc. Given enough samples you would be able to better construct the true
probability distribution of the sum of two dice throws.
This process of sampling scales to larger, more complex multivariate probability
distributions. The QPU has an ability to sample from a more complex distribution
and this is due to the fact that the quantum mechanics that drives the QPU inevitably
introduces fluctuations that act as perturbations that can keep the system out of its
ground state. This ‘restlessness’ provides a complex landscape from which to sample
and thus to enrich the training of the RBM.
We will use the QPU to conduct the classification of lung cancer, but first we must
reduce the dataset from roughly 20,000 gene expressions down to a more manageable
amount.
5.1 Feature Selection
We independently used three main methods of reducing data, namely univariate
variable reduction, XGBoost, and, QCrush. The primary reason for reducing down
9
Figure 5: Histogram of the Sums of Two Dice Being Thrown Trials
the number of variables is due to the physical restraints of the QPU. In addition, we
do so to reduce noise from the set and be able to train solely with the most significant
variables/indicators. Feature selection can be a very complex and important part
of the machine learning process and there are many methods that are generally
considered either filter, wrapper, or embedded methods [22], and then combinations
of these which we refer to as ensemble feature selection methods [23]. For this project
we used filter, wrapper, and embedded methods, specifically we experimented with
the Fisher score, XGBoost [3], and LASSO. For this experiment this made little
difference and the results we report used the Fisher score. This reduced the number
of genes from approximately 20,000 to three different sets with 10,20, and 50 genes.
The results reported below is derived from the set with 10 variables.
An interesting approach that we developed internally was referred to above as
QCrush. We will review this briefly as it will be the subject of a future publication
after we perform more experiments with it. Essentially what QCrush does is that it
compresses many variables into a representation for each patient. This enriches how
much information can be used to represent an object that is to be modeled, which in
this case is a patient. The reason we created such an algorithm is due to limitations
in the architecture of the D-Wave QPU, which limits how many variables can be used
to create a model. Similar approaches have been used including autoencoders [24] to
deal with this issue. QCrush has an advantage in that the encoding can be visualized
in terms of how patients relate to each other. However, the point is that one can use
a method like this to reduce the size of the data to ensure that an optimum amount
of information is utilized for the learning phase of the RBM on the QPU.
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5.2 Training a Quantum Boltzmann Machine
Once the number of features has been reduced there are a set of steps that need to
be taken to train the QBM. Steps 6 through 9 were repeated thrice for each set of
hyper-parameters for greater precision.
1. Partition the dataset. In our case we will train on 80 samples, validate on 10,
and test on 14
2. Normalize the dataset using a standard linear scaling to ensure every datapoint
is between 0 and 1
3. Determine the number of hidden variables and number of samples to use
4. Initialize the quantum sampler
5. Binarize the dataset
6. Clamp the desired result
7. Pass the batches through for training
8. Evaluate results on the validation set
9. Score results on test set
These steps lay out the basic procedure by which the Quantum Boltzmann Machine
is trained. For our procedure we will focus on a the dataset created after performing
an XGBoost.
5.2.1 Partition the Dataset
The dataset created via XGBoost contains 104 patients with 3 significant variables.
In order to accurately validate the models’ performance the patients were partitioned
into training, validation, and testing sets with a 80:10:14 split of the patients.
5.2.2 Normalize the Dataset
Restricted Boltzmann Machines are probabilistic models that seek to encode a com-
plex probability distribution. By performing a linear normalization to the dataset
we are able to utilize this probabilistic property of the model. Furthermore, when we
binarize the dataset in order to represent it with binary samples, to be compatible
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Figure 6: Partitioning the Patient Dataset Into 80 Training, 10 Validation, and 14
Testing
with the QPU, it will be crucial that the values be contained within [0, 1]. This is
because the algorithm that is utilized during this process by the QPU is known as
quadratic unconstrained binary optimization (QUBO) [25] and the vector quantities
must be binary. The D-Wave QPU is designed to excel at solving these types of
problems.
We normalized in the following way:
current element−minimum element
maximum element−minimum element
5.2.3 Determine Hyperparameters
The hyper-parameters for the QBM that we are expressly concerned with are:
i) the number of samples
ii) the number of hidden nodes (i.e. data compression)
iii) the learning rate
With a rudimentary form of hyper-tuning, our approach was simply to iterate over
every number of hidden layers from 1 to 3, learning rate from 0.25 to 1.25 with step
size 0.25, and samples from 1 to 2048 in powers of 2. In the section dedicated to
hyper-tuning we will speak to the results from our hyper-tuning.
5.2.4 Initialize the Quantum Sampler
Create an instance of the QBM class with the hyper-parameters that were deter-
mined. In addition the QBM is initialized with the number of visible nodes (number
of features + classes)(refer to clamping for reasoning).
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5.2.5 Binarize the Dataset
In order to utilize the Quantum Sampler the input data must contain only binary
samples of the dataset, yet the data that is available is not so. Once normalized each
patient is a vector of floating point data points between 0 to 1. To now binarize this
vector of floats we broadcast a single vector into a set of one thousand vectors as
follows. To illustrate with a broadcast to just ten vectors:
Figure 7: Binarization of a Normalized Vector to a Set of Binary Vectors
Every value in a column vector is expanded from being a single value to a vector
of one thousand 1s and 0s, where the number of 1s in the new vector correspond to
the probability encoded by the single value. E.g. if the first variable of the patients’
column vector is normalized to the value 0.7, the new binary vector representation of
that single variable will be a thousand element vector with 700 ones, and 300 zeros
in a random ordering. These 1000 column vectors are treated as a single batch when
training the QBM, meaning each batch contains a single patient represented by 1000
binary vectors.
5.2.6 Clamp the Class
Adenocarcinoma and Squamous Cell Carcinoma are the 2 classes that the patient
data belongs to. Thus we have a clamp of size 2 with [1,0] representing Adenocar-
cinoma and [0, 1] representing Squamous Cell Carcinoma. Once we append these
clamp values to the patient vector we can begin to train.
5.2.7 Training
Every binarized batch of 1000 vectors is trained using the D-Wave quantum com-
puter and the weights matrices are updated to be able to produce more accurate
representations of the dataset. The operation of creating a batch of binarized test
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data and determining the hyper-parameters are in essence the only major require-
ments to train the QBM. Once the QBM is initialized and the dataset is processed
into the aforementioned batches, D-Wave’s libraries handle the task of sampling from
the QPU and using the gathered samples to train the model.
5.2.8 Validation
To validate the classification accuracy of the QBM we compute an error. This error is
the euclidean distance between the vectors representing the clamp value i.e. [1, 0] and
the predicted clamp value. In layman’s terms, we determine an error by summing the
square of the differences between each corresponding vector value of the predicted
and true clamp. The lowest consistent error value indicates the best trained model
with optimal hyper-parameters. To determine the predicted classification we repeat
the same process for normalizing and preprocessing as before, yet instead of providing
the clamp with the actual classification we provide a neutral clamp, i.e., [1, 1]. Then
we simply feed the batch forward, and back, and calculate error.
5.2.9 Testing
Once validated we can test the QBM’s classification accuracy by repeating the same
process as validation. The one difference between validation and testing is that
we will not be testing for an error score, rather a raw value of success/failure in
predication. If the models we create are over-fit we should observe a great disparity
between the error found when validating and the actual test results.
6 Results
• the results of experiment showed that a learning rate of 0.75, 3 hidden neurons,
and 1024 samples produced raw scores of 13, 14, and 13
• the average score being 40
42
= 95.24%.
• observed an increase in prediction accuracy with greater samples, as expected,
and an increase in accuracy with a greater number of hidden nodes, with
dimishing returns.
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7 Future Work
Due to the limitations of time-sharing the D-Wave computer, in addition to con-
straints of the service itself, we were unable to test a greater number of hyper-
parameters and conditions. In the future we hope to further explore the capabilities
and potential optimizations of the D-Wave quantum system. That being said, we
have already constructed interesting models to predict mild vs aggressive cases of
Chronic Lymphocytic Leukemia (CLL). However, a hope that we have and see as a
potential avenue to achieve true quantum supremacy in the near term involves the
ability to explore the molecular and genetic landscape of patient populations.
It is already understood and believed that quantum supremacy can be achieved
on near term quantum devices in the area of drug design. This is due to the fact
that molecules are quantum entities and quantum computers provide a computa-
tional space to perform simulations that is obviously more natural for such a venture.
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This effort is underway by the authors of this paper but we propose a related space
where quantum supremacy may be possible: the aforementioned molecular and ge-
netic landscape of patient populations. To elucidate consider that one can capture
hundreds of miRNA data + 20000 mRNAs + a large number of methylation data
(hundreds of thousands) + single nucleotide polymorphisms (millions) + microbiome
data. This is a monstrous amount of data about each individual and the challenge
is to create algorithms that will help us understand which subset of these variables
actually characterize a patient or person in a meaningful way. For example, is there a
relatively small number of these variables, say approximately 10-30, that could define
a specific sub-type of human that would respond particularly well to a new treatment
of pancreatic cancer? This not only defines a subtype of human, but perhaps a spe-
cific manifestation of the disease. In this way, one would even be able to direct the
activities of drug designers and thus a truly personalized approach to medicine may
be possible. A hopeful perspective, but one tamed by the monstrous complexity in-
volved with this kind of variable reduction. Approaches that are deemed black boxes
cannot help with this task and thus one will need methods that hand over the subsets
of variables, and effectively ‘explain’ themselves. Quantum computation may be able
to play a significant role here because of our ability to utilize quantum parallelism.
Work in this direction that utilized the QUBO [25] algorithm on a quantum annealer
can be found in a white paper here [26]. Much progress has to be made in quantum
computational technologies before problems like this can be truly addressed however
near term machines may be able to make real progress in this direction by allowing
for a more complex and complete sampling space. This will allow novel algorithms
a deeper reach into the space of these variable subsets. We are beginning to explore
this direction through work with the D-Wave technology.
8 Conclusion
We utilized a quantum annealer, namely the D-Wave 2000Q, to create a model ca-
pable of predicting if non-small cell lung cancer patients either have adenocarcinoma
or squamous cell carcinoma, two different varieties of this deadly disease. The abil-
ity to know this can have life altering treatment consequences, especially as cancer
treatment matures and becomes more personalized. The variables used to train the
model was gene expression data derived from tumor samples. Considering that the
machine had access to 104 patients in total, the machine performed very well and we
have reason to believe that the models are robust, as classical methods performed
similarly and replicated well. The effort however was not made to demonstrate quan-
tum supremacy of any kind, but to explore how precision medicine may be impacted
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as near term devices become more powerful. The ability to sample from complex
distributions, something that quantum annealers are able to readily provide, is al-
lowing generative based machine learning models, like ours, to become a reality. In
[4], various approaches like this are explored but an important goal of this same pa-
per was to suggest that near term quantum computers can be utilized to eventually
out perform classical computers but only for certain types of problems and utiliz-
ing certain approaches. Our work here was performed in the same spirit and is an
initiation point for an ongoing effort to explore how this new paradigm of machine
learning will impact the medical space. Precision medicine is the hope of the future
where treatment protocols will be tailored for specific subpopulations of patients. In
order for this to become a reality, we will need to utilize machine learning proto-
cols to understand the disease from the perspective of patient populations and the
various manifestations these classically identified illnesses take. In addition to the
new disease definitions that this effort will bring forth, a new understanding that
will influence treatment paradigms will emerge. We believe that quantum machine
learning, even near term devices, will have an impact.
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